Crossmark

Liraglutide attenuates aluminum chloride-induced Alzheimer’s disease in rats by modulating the oxLDL/LPA/LPAR1 pathway

Crossref DOI link: https://doi.org/10.1038/s42003-026-09531-z

Published Online: 2026-02-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abo El-Magd, Nada F. https://orcid.org/0000-0003-2896-2802
Ramadan, Nehal M. https://orcid.org/0000-0001-8849-7354
Eraky, Salma M.
License Information

Text and Data Mining valid from 2026-02-11

Version of Record valid from 2026-02-17
More Information

Article History

Received: 17 April 2025

Accepted: 5 January 2026

First Online: 11 February 2026

Competing interests

: The authors declare no competing interests.